🍽🦠 PubMed Studies Citing Bacteria Shifts for lactobacillus rhamnosus gg,bifidobacterium animalis lactis ,lactobacillus paracasei {cvs maximum strength probiotic} - Lactobacillus amylolyticus

Citations are updated once a week. Recently added citations may not appear.

9 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
📓 - Direct Citation   |   👪 - Infer Parent  |   👶 - Infer Child |   ⚗️ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😢 - Shifts in wrong direction
Context Citation
lactobacillus rhamnosus gg,bifidobacterium animalis lactis ,lactobacillus paracasei {cvs maximum strength probiotic} - Lactobacillus amylolyticus    👶 Probiotic Lactobacillus rhamnosus GG improves insulin sensitivity and offspring survival via modulation of gut microbiota and serum metabolite in a sow model.
Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 15 Issue 1 Pages: 89
Pub: 2024 Jul 2 Epub: 2024 Jul 2 Authors Gao T , Li R , Hu L , Hu Q , Wen H , Zhou R , Yuan P , Zhang X , Huang L , Zhuo Y , Xu S , Lin Y , Feng B , Che L , Wu D , Fang Z ,
Html Article Publication
lactobacillus rhamnosus gg,bifidobacterium animalis lactis ,lactobacillus paracasei {cvs maximum strength probiotic} - Lactobacillus amylolyticus    👶 Effects of a formula with a probiotic Bifidobacterium lactis Supplement on the gut microbiota of low birth weight infants.
European journal of nutrition (Eur J Nutr ) Vol: 59 Issue 4 Pages: 1493-1503
Pub: 2020 Jun Epub: 2019 Jun 13 Authors Chi C , Xue Y , Liu R , Wang Y , Lv N , Zeng H , Buys N , Zhu B , Sun J , Yin C ,
Publication
lactobacillus rhamnosus gg,bifidobacterium animalis lactis ,lactobacillus paracasei {cvs maximum strength probiotic} - Lactobacillus amylolyticus    👶 Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis ) Vol: 40 Issue 1 Pages: 28-37
Pub: 2005 Jan 1 Epub: 2004 Dec 6 Authors Bartosch S , Woodmansey EJ , Paterson JC , McMurdo ME , Macfarlane GT ,
Publication
lactobacillus rhamnosus gg,bifidobacterium animalis lactis ,lactobacillus paracasei {cvs maximum strength probiotic} - Lactobacillus amylolyticus    👶 Beneficial effects of the commercial lactic acid bacteria product, Vigiis 101, on gastric mucosa and intestinal bacterial flora in rats.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect ) Vol: Issue Pages:
Pub: 2018 Jun 23 Epub: 2018 Jun 23 Authors Kao L , Liu TH , Tsai TY , Pan TM ,
Publication Publication
lactobacillus rhamnosus gg,bifidobacterium animalis lactis ,lactobacillus paracasei {cvs maximum strength probiotic} - Lactobacillus amylolyticus    👶 Lactobacillus paracasei subsp. paracasei LC01 positively modulates intestinal microflora in healthy young adults.
Journal of microbiology (Seoul, Korea) (J Microbiol ) Vol: 51 Issue 6 Pages: 777-82
Pub: 2013 Dec Epub: 2013 Dec 19 Authors Zhang H , Sun J , Liu X , Hong C , Zhu Y , Liu A , Li S , Guo H , Ren F ,
Publication Publication

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]